GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sun Pharma Advanced Research Co Ltd (NSE:SPARC) » Definitions » Book Value per Share

Sun Pharma Advanced Research Co (NSE:SPARC) Book Value per Share : ₹-6.68 (As of Mar. 2025)


View and export this data going back to 2007. Start your Free Trial

What is Sun Pharma Advanced Research Co Book Value per Share?

Sun Pharma Advanced Research Co's book value per share for the quarter that ended in Mar. 2025 was ₹-6.68.

During the past 12 months, Sun Pharma Advanced Research Co's average Book Value Per Share Growth Rate was -100.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Sun Pharma Advanced Research Co was 180.40% per year. The lowest was -53.30% per year. And the median was 3.10% per year.

Sun Pharma Advanced Research Co's current price is ₹167.03. Its book value per share for the quarter that ended in Mar. 2025 was ₹-6.68. Hence, today's PB Ratio of Sun Pharma Advanced Research Co is .

During the past 13 years, the highest P/B Ratio of Sun Pharma Advanced Research Co was 1639.66. The lowest was 10.27. And the median was 53.16.

Good Sign:

Sun Pharma Advanced Research Co Ltd stock PB Ratio (=41.6) is close to 1-year low of 41.6.


Sun Pharma Advanced Research Co Book Value per Share Historical Data

The historical data trend for Sun Pharma Advanced Research Co's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sun Pharma Advanced Research Co Book Value per Share Chart

Sun Pharma Advanced Research Co Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Book Value per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.42 1.15 15.80 3.88 -6.68

Sun Pharma Advanced Research Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.88 - - - -6.68

Competitive Comparison of Sun Pharma Advanced Research Co's Book Value per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Sun Pharma Advanced Research Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sun Pharma Advanced Research Co's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sun Pharma Advanced Research Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Sun Pharma Advanced Research Co's PB Ratio falls into.


;
;

Sun Pharma Advanced Research Co Book Value per Share Calculation

Sun Pharma Advanced Research Co's Book Value Per Share for the fiscal year that ended in Mar. 2025 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(-2,169.5-0.0)/324.7
=-6.68

Sun Pharma Advanced Research Co's Book Value Per Share for the quarter that ended in Mar. 2025 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(-2,169.5-0.0)/324.8
=-6.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


Sun Pharma Advanced Research Co  (NSE:SPARC) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Sun Pharma Advanced Research Co Book Value per Share Related Terms

Thank you for viewing the detailed overview of Sun Pharma Advanced Research Co's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Sun Pharma Advanced Research Co Business Description

Traded in Other Exchanges
Address
Off Mahakali Caves Road, 17-B, Mahal Industrial Estate, Andheri (East), Mumbai, MH, IND, 400093
Sun Pharma Advanced Research Co Ltd is an Indian specialty and generic drug manufacturing company. The company has identified pharmaceuticals research and development as its only reportable segment. The company is focused on drug discovery in focused therapy areas such as cancer and anti-inflammatory treatments. The company considers merger and acquisition investment as a potential component of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities. It derives maximum revenue from India and also has its presence in othe4r countries.

Sun Pharma Advanced Research Co Headlines

No Headlines